Neurocrine Biosciences | Capitalização De Mercado



Market Capitalization Alterar Data
AbbVie USD 327.88B 42.76B 2025-06
Acadia Pharmaceuticals USD 3.61B 840M 2025-06
Agios Pharmaceuticals USD 1.93B 234M 2025-06
ALKERMES USD 4.72B 725M 2025-06
Alnylam Pharmaceuticals USD 42.52B 7.39B 2025-06
Amgen USD 150.13B 17.37B 2025-06
Biogen USD 18.41B 1.62B 2025-06
BioMarin Pharmaceutical USD 10.54B 3.01B 2025-06
Cytokinetics USD 3.95B 846M 2025-06
Dynavax Technologies USD 1.19B 421M 2025-06
Gilead Sciences USD 137.91B 1.77B 2025-06
Halozyme Therapeutics USD 6.41B 1.47B 2025-06
Incyte USD 13.18B 1.46B 2025-06
Ionis Pharmaceuticals USD 6.29B 1.49B 2025-06
Neurocrine Biosciences USD 12.44B 1.5B 2025-06
Pfizer USD 137.53B 6.19B 2025-06
Prothena USD 441M 114M 2025-09
Regeneron Pharmaceuticals USD 55.87B 13.47B 2025-06
Repligen USD 6.99B 160M 2025-06
Sarepta Therapeutics USD 1.68B 4.51B 2025-06
Teva Pharmaceutical Industries ILS 65.36B 1.34B 2025-06
Ultragenyx Pharmaceutical USD 3.44B 38M 2025-06
Vertex Pharmaceuticals USD 114.33B 10.31B 2025-06


Neurocrine Biosciences Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.